Home / Recalls / Wuhan Bingbing Pharmaceutical Co., Ltd. / D-1277-2020

D-1277-2020 Class II Ongoing

Recalled by Wuhan Bingbing Pharmaceutical Co., Ltd. — Wuhan, N/A

Recall Details

Product Type
Drugs
Report Date
June 3, 2020
Initiation Date
May 19, 2020
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,960 boxes

Product Description

LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.

Reason for Recall

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Distribution Pattern

Nationwide in the USA

Code Information

Batch #: 1180103, Exp 2021.01.02; 180104, Exp 2021.01.03; 80105, Exp 2021.01.04; 180106, Exp 2021.01.05; 80107, Exp 2021.01.06.

Other recalls by Wuhan Bingbing Pharmaceutical Co., Ltd.

  • D-1278-2020 Class II — LidoPro (lidocaine 4%, menthol 5%, methyl salicylate 4%) patch, 15 Patches per b (May 19, 2020)
  • D-1280-2020 Class II — Maximum Strength Lidocaine Cold & Hot Patch (lidocaine 4%, menthol 1%), 5 patche (May 19, 2020)
  • D-1279-2020 Class II — Mencaine (lidocaine 4.5%, menthol 5%) Patch, 1 patch per pouch, Manufactured For (May 19, 2020)